Common use of EFFECTIVE AND BINDING AGREEMENT Clause in Contracts

EFFECTIVE AND BINDING AGREEMENT. Paksn and OIG agree as follows: A. This CIA constitutes the complete agreement between the parties and may not be amended except by written consent of the parties to this CIA. B. All requirements and remedies set forth in this CIA are in addition to and do not affect (1) Paksn’s responsibility to follow all applicable Federal health care program requirements or (2) the government’s right to impose appropriate remedies for failure to follow applicable Federal health care program requirements. C. The undersigned Paksn signatories represent and warrant that they are authorized to execute this CIA. The undersigned OIG signatories represent that they are signing this CIA in their official capacities and that they are authorized to execute this CIA. D. This CIA may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same CIA. Electronically transmitted copies of signatures shall constitute acceptable, binding signatures for purposes of this CIA. /Xxxxx Xxxxxxx/ 11/8/2023 Xxxxx Xxxxxxx DATE Owner /Xxxxx Xxxxx/ 11/8/2023 Xxxxx Xxxxx DATE Counsel for Paksn /Xxxxxxx Xxxxxx/ 11/8/23 Xxxxxxx Xxxxxx DATE Counsel for Paksn /Xxxx Re/ 2023.11.09 XXXX X. RE DATE Assistant Inspector General for Legal Affairs Office of Inspector General U. S. Department of Health and Human Services /Xxxxxxx Xxxxxxx/ 2023.11.09 Office of Inspector General U.S. Department of Health and Human Services This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E of the CIA.

EFFECTIVE AND BINDING AGREEMENT. Paksn The Parties and OIG agree as follows: A. This CIA constitutes the complete agreement between the parties and may not be amended except by written consent of the parties to this CIA. B. All requirements and remedies set forth in this CIA are in addition to and do not affect (1) Paksn’s the Parties’ responsibility to follow all applicable Federal health care program requirements or (2) the government’s right to impose appropriate remedies for failure to follow applicable Federal health care program requirements. C. The undersigned Paksn Citadel and Plaza signatories represent and warrant that they are authorized to execute this CIA. The undersigned OIG signatories represent that they are signing this CIA in their official capacities and that they are authorized to execute this CIA. D. This CIA may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same CIA. Electronically transmitted copies of signatures shall constitute acceptable, binding signatures for purposes of this CIA. /Xxxxx Xxxxxxx/ 11/8/2023 Xxxxx Xxxxxxx Xxx-Xxxxxx/ __6/14/22 XXXXX XXX-XXXXXX DATE Owner General Counsel TCPRNC, LLC /Xxxxx Xxxxx/ 11/8/2023 Xxxxx Xxxxx Xxx-Xxxxxx/ __6/14/22 XXXXX XXX-XXXXXX DATE General Counsel for Paksn /Xxxxxxx Xxxxxx/ 11/8/23 Xxxxxxx Xxxxxx DATE Counsel for Paksn Citadel Consulting Group LLC /Xxxx X. Re/ 2023.11.09 6/13/2022 XXXX X. RE DATE Assistant Inspector General for Legal Affairs Office of Inspector General U. S. U.S. Department of Health and Human Services /Xxxxxxx /Xxxxx Xxxxxxx/ 2023.11.09 June 17, 2022 XXXXX XXXXXXX DATE Senior Counsel Office of Inspector General U.S. Department of Health and Human Services This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E III.D of the CIA.

EFFECTIVE AND BINDING AGREEMENT. Paksn Provider and OIG agree as follows: A. This CIA constitutes the complete agreement between the parties and may not be amended except by written consent of the parties to this CIA. B. All requirements and remedies set forth in this CIA are in addition to and do not affect (1) PaksnProvider’s responsibility to follow all applicable Federal health care program requirements or (2) the government’s right to impose appropriate remedies for failure to follow applicable Federal health care program requirements. C. The undersigned Paksn Provider signatories represent and warrant that they are authorized to execute this CIA. The undersigned OIG signatories represent that they are signing this CIA in their official capacities and that they are authorized to execute this CIA. D. This CIA may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same CIA. Electronically transmitted copies of signatures shall constitute acceptable, binding signatures for purposes of this CIA. /Xxxxx Xxxxxxx/ 11/8/2023 Xxxxx Xxxxxxx Xxxxxx/ 5/21/24 XXXXX XXXXXX DATE Owner Chief Financial Officer /Xxxxx Xxxxx/ 11/8/2023 Xxxxx Xxxxx Xxxxxx/ 5/21/24 XXXXX XXXXXX DATE Counsel for Paksn /Xxxxxxx Chief Financial Officer /Xxxxx Xxxxxx/ 11/8/23 Xxxxxxx Xxxxxx 5/21/24 XXXXX XXXXXX DATE Counsel for Paksn /Xxxx Re/ 2023.11.09 XXXX Chief Financial Officer /Xxxxx Xxxxxx/ 5/21/24 XXXXX X. RE XXXXXX DATE Assistant Inspector General for Legal Affairs Office of Inspector General U. S. Department of Health and Human Services /Xxxxxxx Xxxxxxx/ 2023.11.09 Office of Inspector General U.S. Department of Health and Human Services This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E of the CIA.Services

EFFECTIVE AND BINDING AGREEMENT. Paksn Rite Aid and OIG agree as follows: A. This CIA constitutes the complete agreement between the parties and may not be amended except by written consent of the parties to this CIA. B. All requirements and remedies set forth in this CIA are in addition to and do not affect (1) PaksnRite Aid’s responsibility to follow all applicable Federal health care program requirements or (2) the government’s right to impose appropriate remedies for failure to follow applicable Federal health care program requirements. C. The undersigned Paksn Rite Aid signatories represent and warrant that they are authorized to execute this CIA. The undersigned OIG signatories represent that they are signing this CIA in their official capacities and that they are authorized to execute this CIA. D. This CIA may be executed in counterparts, each of which constitutes an original and all of which constitute one and the same CIA. Electronically transmitted copies of signatures shall constitute acceptable, binding signatures for purposes of this CIA. /Xxxxx Xxxxxxx/ 11/8/2023 /Xxxxxxx X. Xxxxx/ July 9, 2024 Xxxxxxx X. Xxxxx Xxxxxxx DATE Owner /Xxxxx Xxxxx/ 11/8/2023 Xxxxx Xxxxx Chief Executive Officer _/Xxxx Xxxxxxxxx/ July 9, 2024 Xxxx Xxxxxxxxx DATE Counsel for Paksn /Xxxxxxx Xxxxxx/ 11/8/23 Xxxxxxx Rite Aid /Xxxxxx XxXxxxx/ 07/09/24 Xxxxxx XxXxxxx DATE Chief Counsel for Paksn /Xxxx Re/ 2023.11.09 XXXX X. RE DATE Assistant to the Inspector General for Legal Affairs Office of Inspector General U. S. Department of Health and Human Services /Xxxxxxx Xxxxxxx/ 2023.11.09 Office of Inspector General U.S. Department of Health and Human Services /Xxxxxxxxx XxXxxxxx/ 2024.07.09 Xxxxxxxxx X. XxXxxxxx DATE Senior Counsel Office of Counsel to the Inspector General This Appendix contains the requirements relating to the Independent Review Organization (IRO) required by Section III.E III.D of the CIA.